The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Urology Oncology Année : 2023

The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study

Estelle Aymes
  • Fonction : Auteur
Meryem Brihoum
  • Fonction : Auteur
Soazig Nenan
  • Fonction : Auteur
Fichier non déposé

Dates et versions

hal-04436604 , version 1 (03-02-2024)

Identifiants

Citer

David Pasquier, Thomas Lacornerie, Stéphane Supiot, Pascal Pommier, Magali Quivrin, et al.. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. European Urology Oncology, 2023, 6 (4), pp.399-405. ⟨10.1016/j.euo.2023.01.009⟩. ⟨hal-04436604⟩
18 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More